Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | +8.39% | +3.53% | -16.75% |
04-18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
03-12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Evolution of the average Target Price on Anixa Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Anixa Biosciences, Inc.
HC Wainwright | |
Chardan Research |
EPS Revisions
- Stock Market
- Equities
- ANIX Stock
- Consensus Anixa Biosciences, Inc.